AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Family Practice newspaper is a magazine specializing in Caregiving topics.
Set up an RSS feed
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Family Practice News back issues
|
|
Cancer survivors lack ideal screening.(NEWS)
June 15, 2009... [ILLUSTRATION OMITTED]
ORLANDO -- Fewer than half of childhood cancer survivors who are deemed to be at high risk of secondary breast, colon, and skin malignancies follow cancer-screening and surveillance recommendations as adults, according to a new analysis of the large, longitudinal...
Biyearly zoledronic acid gets nod for prevention.(NEWS FROM THE FDA)
June 15, 2009... The Food and Drug Administration has approved biyearly dosing of the osteoporosis drug zoledronic acid (Reclast) for the prevention of bone loss in postmenopausal women, making it the first bisphosphonate in its class to get the nod for a 2-year indication.
The approval is based on...
Our publishing schedule shifts to cut costs.(ASK THE EXPERT)(Editorial)
June 15, 2009... FAMILY PRACTICE NEWS will be published once monthly in July, August, and December this year. These reductions in the frequency are being taken to cut costs during these difficult economic times.
At the same time, the staff of FAMILY PRACTICE NEWS pledges to keep bringing you the...
Analysis backs benazepril-amlodipine combo.(CARDIOVASCULAR MEDICINE)
June 15, 2009... SAN FRANCISCO -- A new analysis supports a controversial study that challenged the favored role of diuretics in combination therapy for hypertension, but some experts remain skeptical.
Dr. Kenneth Jamerson, lead investigator of the Avoiding Cardiovascular Events Through Combination...
Trial quantifies exercise benefits in heart failure.(CARDIOVASCULAR MEDICINE)(Report)
June 15, 2009... ORLANDO -- Heart failure patients who engage in aerobic activity can lower their risk of all-cause mortality or hospitalization, according to a new secondary analysis of data from a major National Heart, Lung, and Blood Institute--sponsored randomized trial.
"'It appears that only a...